Brain ischemia as a target for Ca2+ entry blockers.
Wauquier
A
A
Department of Neuropharmacology, Janssen Pharmaceutica, Beerse, Belgium.
Ashton
D
D
Clincke
G H
GH
D000818:Animals; D002545:Brain Ischemia / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D002121:Calcium Channel Blockers / Q000494:pharmacology* / Q000627:therapeutic use; D002560:Cerebrovascular Circulation / Q000187:drug effects
D002121:Calcium Channel Blockers